Ignite Creation Date:
2025-12-24 @ 2:52 PM
Ignite Modification Date:
2026-02-23 @ 8:31 PM
Study NCT ID:
NCT05525559
Status:
UNKNOWN
Last Update Posted:
2022-09-01
First Post:
2022-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
SHP2 Inhibitor ET0038 Monotherapy in Patients With Advanced Solid Tumors
Sponsor:
Etern BioPharma (Shanghai) Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ET0038-101 US
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None